T1	CHEM 71 81	aticaprant
T2	CHEM 96 109	antidepresivo
#1	AnnotatorNotes T2	C0003289; Antidepressive Agents; Pharmacologic Substance
T3	Date 110 116	actual
T4	Duration 142 148	un año
T5	Spec_cue 161 169	ayudaría
T6	Speculated 172 179	mejorar
T7	DISO 183 192	depresión
#2	AnnotatorNotes T7	C0011570; Mental Depression; Mental or Behavioral Dysfunction | C0011581; Depressive disorder; Mental or Behavioral Dysfunction | C0344315; Depressed mood; Mental or Behavioral Dysfunction
T8	Speculated 183 192	depresión
T9	PROC 217 248	estudio abierto y a largo plazo
T10	Date 235 248	a largo plazo
T11	PROC 254 288	evaluar la seguridad y la eficacia
T12	CHEM 292 302	aticaprant
T13	PROC 308 334	tratamiento complementario
#3	AnnotatorNotes T13	C0936077; Complementary therapies; Therapeutic or Preventive Procedure
T14	LIVB 338 364	participantes adultos y de
T15	Age 352 359	adultos
T16	Age 365 378	edad avanzada
T17	DISO 383 408	trastorno depresivo mayor
#4	AnnotatorNotes T17	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T18	DISO 410 413	TDM
#5	AnnotatorNotes T18	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T19	DISO 437 446	Depresión
#6	AnnotatorNotes T19	C0011570; Mental Depression; Mental or Behavioral Dysfunction | C0011581; Depressive disorder; Mental or Behavioral Dysfunction | C0344315; Depressed mood; Mental or Behavioral Dysfunction
T20	DISO 471 496	Trastorno depresivo mayor
#7	AnnotatorNotes T20	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T21	DISO 498 501	TDM
#8	AnnotatorNotes T21	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T22	LIVB 529 542	Participantes
T23	LIVB 574 587	participantes
T24	PROC 619 642	tratamiento doble ciego
T25	LIVB 697 709	participante
T26	PROC 750 763	examen físico
#9	AnnotatorNotes T26	C0031809; Physical Examination; Health Care Activity
T27	PROC 790 804	signos vitales
T28	PROC 818 834	presión arterial
T29	PROC 841 863	ECG de 12 derivaciones
T30	PROC 907 918	tratamiento
#10	AnnotatorNotes T30	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T31	LIVB 940 953	Participantes
T32	LIVB 977 979	De
T33	LIVB 980 994	sexo masculino
T34	LIVB 997 1005	femenino
T35	Age 1007 1022	de 18 a 74 años
T36	DISO 1178 1181	TDM
#11	AnnotatorNotes T36	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T37	Neg_cue 1214 1217	sin
T38	Negated 1218 1244	características psicóticas
T39	LIVB 1250 1263	participantes
T40	Age 1267 1280	65 años o más
T41	DISO 1325 1334	depresión
#12	AnnotatorNotes T41	C0011570; Mental Depression; Mental or Behavioral Dysfunction | C0011581; Depressive disorder; Mental or Behavioral Dysfunction | C0344315; Depressed mood; Mental or Behavioral Dysfunction
T42	Age 1348 1355	55 años
T43	Neg_cue 1421 1423	no
T44	Negated 1424 1447	más de 3 antidepresivos
T45	Dose 1424 1430	más de
T46	CHEM 1433 1447	antidepresivos
#13	AnnotatorNotes T46	C0003289; Antidepressive Agents; Pharmacologic Substance
T47	Date 1523 1529	actual
T48	DISO 1533 1542	depresión
#14	AnnotatorNotes T48	C0011570; Mental Depression; Mental or Behavioral Dysfunction | C0011581; Depressive disorder; Mental or Behavioral Dysfunction | C0344315; Depressed mood; Mental or Behavioral Dysfunction
T49	CHEM 1584 1588	ISRS
#15	AnnotatorNotes T49	C0360105; Selective Serotonin Reuptake Inhibitors; Pharmacologic Substance
T50	CHEM 1589 1593	IRSN
#16	AnnotatorNotes T50	C3537213; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]; Pharmacologic Substance
T51	DISO 1599 1618	síntomas depresivos
#17	AnnotatorNotes T51	C0086132; Depressive Symptoms; Sign or Symptom
T52	Duration 1673 1691	al menos 6 semanas
T53	PROC 1755 1778	entrevista de selección
T54	PROC 1785 1821	Escala de evaluación de la depresión
T55	PROC 1825 1833	Hamilton
T56	Neg_cue 1860 1863	sin
T57	Negated 1868 1874	mejora
T58	Negated 1875 1891	superior al 20 %
T59	PROC 1919 1929	evaluación
#18	AnnotatorNotes T59	C1261322; Evaluation procedure; Health Care Activity
T60	LIVB 1958 1971	Participantes
T61	LIVB 2002 2014	participante
T62	Neg_cue 2015 2017	no
T63	Negated 2018 2066	cumplió con la administración de la intervención
T64	PROC 2033 2066	administración de la intervención
T65	PROC 2093 2116	tratamiento doble ciego
T66	PROC 2118 2120	DB
T67	PROC 2193 2203	evaluación
#19	AnnotatorNotes T67	C1261322; Evaluation procedure; Health Care Activity
T68	PROC 2238 2262	continuar el tratamiento
T69	CHEM 2267 2279	aticacaprant
T70	Neg_cue 2280 2282	no
T71	Negated 2286 2295	favorable
T72	LIVB 2304 2316	participante
T73	LIVB 2332 2344	investigador
#20	AnnotatorNotes T73	C0035173; Research Personnel; Professional or Occupational Group
T74	LIVB 2352 2364	participante
T75	DISO 2376 2414	ideas suicidas con intención de actuar
T76	DISO 2417 2439	comportamiento suicida
#21	AnnotatorNotes T76	C1760428; Suicidal behavior; Finding
T77	LIVB 2469 2481	participante
T78	PROC 2502 2509	terapia
#22	AnnotatorNotes T78	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T79	Contraindicated 2502 2509	terapia
T80	Neg_cue 2524 2526	no
T81	Negated 2541 2553	dosificación
T82	Date 2557 2565	el Día 1
T83	PROC 2599 2606	terapia
#23	AnnotatorNotes T83	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T84	LIVB 2647 2659	participante
T85	LIVB 2737 2749	investigador
#24	AnnotatorNotes T85	C0035173; Research Personnel; Professional or Occupational Group
T86	Neg_cue 2768 2770	no
T87	Speculated 2780 2785	mejor
T88	LIVB 2794 2806	participante
T89	Spec_cue 2848 2854	podría
T90	Speculated 2855 2862	impedir
T91	Speculated 2864 2871	limitar
T92	Speculated 2874 2883	confundir
T93	PROC 2888 2900	evaluaciones
#25	AnnotatorNotes T93	C1261322; Evaluation procedure; Health Care Activity
T94	PROC 2921 2930	protocolo
#26	AnnotatorNotes T94	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T95	LIVB 2932 2945	Participantes
T96	LIVB 2972 2984	participante
T97	Neg_cue 2985 2994	carece de
T98	Negated 2999 3005	mejora
T99	Negated 3006 3018	clínicamente
T100	CHEM 3049 3053	ISRS
#27	AnnotatorNotes T100	C0360105; Selective Serotonin Reuptake Inhibitors; Pharmacologic Substance
T101	CHEM 3054 3058	IRSN
#28	AnnotatorNotes T101	C3537213; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]; Pharmacologic Substance
T102	Date 3059 3065	actual
T103	PROC 3152 3173	terapia antidepresiva
T104	Date 3174 3180	actual
T105	DISO 3207 3242	trastorno por consumo de sustancias
T106	DISO 3276 3308	trastorno por consumo de alcohol
T107	Duration 3342 3353	los 6 meses
T108	Duration 3399 3417	los últimos 5 años
T109	PROC 3424 3449	tratamiento antidepresivo
T110	CHEM 3461 3469	ketamina
#29	AnnotatorNotes T110	C0022614; ketamine; Organic Chemical · Pharmacologic Substance
T111	CHEM 3470 3480	esketamina
T112	PROC 3482 3507	terapia electroconvulsiva
#30	AnnotatorNotes T112	C0013806; Electroconvulsive Therapy; Therapeutic or Preventive Procedure
T113	PROC 3530 3542	tratamientos
#31	AnnotatorNotes T113	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T114	PROC 3545 3574	estimulación del nervio vagal
T115	DEVI 3580 3625	dispositivo de estimulación cerebral profunda
T116	DISO 3639 3643	idea
T117	DISO 3644 3662	intención homicida
T118	Date 3663 3669	actual
T119	LIVB 3699 3711	investigador
#32	AnnotatorNotes T119	C0035173; Research Personnel; Professional or Occupational Group
T120	DISO 3721 3735	ideas suicidas
#33	AnnotatorNotes T120	C0424000; Feeling suicidal (finding); Finding
T121	Duration 3777 3788	los 3 meses
